All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kaitlin_rios on TikTok · 37s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kaitlin_rios's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00If you're on this or you're considering trying GHK-Cu, you also need this. Okay, this is going to
  2. 0:08help you in that purge phase of your skin. Highly recommend. I started incorporating this with my
  3. 0:14GHK-Cu and I'm seeing great results. Okay, I'm going to insert a video of what my skin looked like
  4. 0:19in the beginning of this journey. That was after week one. Now we're about, I think we're about six
  5. 0:26weeks in. I have no makeup on. This is what we're looking like now. I mean, the proof is in the pudding.
  6. 0:34Okay.

GHK-Cu for cystic acne and skin: what the evidence says

Kaitlin Rios

TikTok creator

82.6K viewsWatch on TikTok

Quick answer

GHK-Cu (copper tripeptide-1) has documented anti-inflammatory and collagen-stimulating properties in peer-reviewed literature, primarily from in vitro and small topical studies, but no randomized controlled trial has evaluated it specifically for cystic acne. The creator's reported improvement over six weeks cannot be attributed to GHK-Cu alone given an unidentified co-intervention and no controls. Patients with cystic acne should consult a dermatologist before substituting or supplementing with peptide-based protocols.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GHK-Cu for cystic acne and skin: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GHK-Cu (Copper Peptide) should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GHK-Cu for cystic acne and skin: what the evidence says" from Kaitlin Rios. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GHK-Cu (copper tripeptide-1) has documented anti-inflammatory and collagen-stimulating properties in peer-reviewed literature, primarily from in vitro and small topical studies, but no randomized controlled trial has evaluated it specifically for cystic acne.

The reason this review is not generic is the source wording and the canonical claim label "peptides what does proof is in the pudding even mean idk but the skin." In this clip, the useful excerpt is: "If you're on this or you're considering trying GHK-Cu, you also need this." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

No randomized controlled trial has tested GHK-Cu as a treatment for cystic acne specifically.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GHK-Cu (copper tripeptide-1) has documented anti-inflammatory and collagen-stimulating properties in peer-reviewed literature, primarily from in vitro and small topical studies, but no randomized controlled trial has evaluated it specifically for cystic acne.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GHK-Cu (copper tripeptide-1) has documented anti-inflammatory and collagen-stimulating properties in peer-reviewed literature, primarily from in vitro and small topical studies, but no randomized controlled trial has evaluated it specifically for cystic acne. The creator's reported improvement over six weeks cannot be attributed to GHK-Cu alone given an unidentified co-intervention and no controls. Patients with cystic acne should consult a dermatologist before substituting or supplementing with peptide-based protocols.
  • GHK-Cu has peer-reviewed support for anti-inflammatory and collagen-stimulating effects in skin, primarily from topical formulation studies (Pickart and Margolina, 2018, Cosmetics).
  • No randomized controlled trial has tested GHK-Cu as a treatment for cystic acne specifically.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu has peer-reviewed support for anti-inflammatory and collagen-stimulating effects in skin, primarily from topical formulation studies (Pickart and Margolina, 2018, Cosmetics).
  • No randomized controlled trial has tested GHK-Cu as a treatment for cystic acne specifically.
  • A 'purge phase' is a validated concept for retinoids due to accelerated cell turnover, but this mechanism has not been demonstrated or published for copper peptides.
  • The unnamed second product in this stack is a safety and efficacy blind spot. Viewers cannot evaluate what they cannot identify.
  • Six-week single-subject before-and-afters cannot establish causation, particularly with two interventions running simultaneously.
  • Cystic acne has evidence-based treatments including retinoids, benzoyl peroxide, and isotretinoin. GHK-Cu may have adjunctive potential but is not a validated primary treatment.
  • Topical and injectable GHK-Cu have meaningfully different bioavailability profiles. The form used was not disclosed in this video.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kaitlin_rios actually say?

Kaitlin showed a before-and-after of her skin at week one versus six weeks into using GHK-Cu, paired with an unnamed secondary product. She told viewers that second product "is going to help you in that purge phase." She had no makeup on and the skin improvement looked real. Her core claim is that the combination produced visible results, and that anyone considering GHK-Cu should also use this mystery product. She never named the second product, never disclosed her GHK-Cu formulation or route, and offered no controls.

That framing matters. She is not claiming GHK-Cu alone cleared her skin. She is claiming a stack did, which makes the attribution nearly impossible to parse. And the concept of a "purge phase" for skin deserves its own scrutiny, because that term gets thrown around in skincare circles to explain away irritation that may or may not be therapeutic.

Does the science back this up?

GHK-Cu (copper tripeptide-1) has real, peer-reviewed support for skin remodeling, but the evidence base is mostly in vitro or small clinical studies, not randomized controlled trials on cystic acne. Pickart and Margolina (2018, Cosmetics) documented GHK-Cu's role in activating skin repair genes and reducing inflammation markers, which is plausible mechanistic support for acne improvement. Gorouhi and Maibach (2009, Skin Pharmacology and Physiology) reviewed copper peptides in wound healing and found legitimate dermal remodeling activity.

The acne-specific evidence is thinner. Cystic acne is driven by sebaceous gland activity, Cutibacterium acnes proliferation, and inflammatory cascades. GHK-Cu has documented anti-inflammatory properties, but no published RCT has tested it head-to-head against standard acne treatments. A six-week before-and-after on one person proves exactly nothing scientifically, even if the photos are genuine. Skin also changes week to week based on hormones, diet, stress, and sleep.

What did they get wrong (or right)?

Credit where it is due: GHK-Cu is not snake oil. The anti-inflammatory and collagen-stimulating mechanisms are reasonably well-supported for skin health in general. Her timeline of six weeks is also plausible for seeing early results from a peptide-based skin intervention. She did not make any wild disease-cure claims and she showed her face without filters or makeup, which is more honest than most influencer skincare content.

What she got wrong: the "purge phase" framing is borrowed from retinoid skincare lore and does not cleanly apply to GHK-Cu. Retinoids cause a documented purge by accelerating cell turnover. GHK-Cu does not work the same way, and there is no published literature describing a purge phase specific to copper peptides. If her skin got worse before it got better, that could reflect the unnamed second product, a coincidental hormonal flare, or genuine irritation. Calling it a predictable purge implies a mechanism that has not been established for this compound.

What should you actually know?

GHK-Cu is a naturally occurring tripeptide found in human plasma that declines with age. Topical and injectable formulations exist, and their bioavailability profiles are quite different. Most of the published skin research uses topical formulations at concentrations between 0.1 and 1 percent. Injectable GHK-Cu has a different pharmacokinetic profile and the evidence base for systemic skin effects is much weaker.

For cystic acne specifically, standard-of-care options backed by robust trial data include topical retinoids, benzoyl peroxide, oral antibiotics, and isotretinoin. GHK-Cu may have adjunctive value for inflammation and scarring, but positioning it as a primary cystic acne intervention is ahead of the evidence. Anyone with cystic acne should be working with a dermatologist, not building a stack from a TikTok recommendation. The unnamed second product is a real problem here. Viewers cannot evaluate safety, interactions, or efficacy for something they cannot identify.

  • GHK-Cu has legitimate anti-inflammatory and tissue-repair data behind it, mostly from topical studies.
  • No published RCT specifically tests GHK-Cu for cystic acne outcomes.
  • The "purge phase" concept is not validated for copper peptides in the literature.
  • One person's six-week before-and-after cannot establish causation, especially with an unidentified second variable in the stack.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Kaitlin Rios · TikTok creator

82.6K views on this video

What does “proof is in the pudding” even mean 🤣🤣 idk but the skin is skinning! #ghkcu #peptide #hairskinnails #cysticacne

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu has peer-reviewed support for anti-inflammatory?

GHK-Cu has peer-reviewed support for anti-inflammatory and collagen-stimulating effects in skin, primarily from topical formulation studies (Pickart and Margolina, 2018, Cosmetics).

What does the video say about no randomized controlled trial has tested ghk-cu as a treatment?

No randomized controlled trial has tested GHK-Cu as a treatment for cystic acne specifically.

What does the video say about a 'purge phase'?

A 'purge phase' is a validated concept for retinoids due to accelerated cell turnover, but this mechanism has not been demonstrated or published for copper peptides.

What does the video say about the unnamed second product in this stack?

The unnamed second product in this stack is a safety and efficacy blind spot. Viewers cannot evaluate what they cannot identify.

What does the video say about six-week single-subject before-and-afters cannot establish causation, particularly with two interventions?

Six-week single-subject before-and-afters cannot establish causation, particularly with two interventions running simultaneously.

What does the video say about cystic acne has evidence-based treatments including retinoids, benzoyl peroxide,?

Cystic acne has evidence-based treatments including retinoids, benzoyl peroxide, and isotretinoin. GHK-Cu may have adjunctive potential but is not a validated primary treatment.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Kaitlin Rios, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.